vandetanib

kinesin family member 5B ; Homo sapiens







4 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 29908090 Drug resistance profiles of mutations in the RET kinase domain. 2018 Sep 1
2 27683183 RET Aberrations in Diverse Cancers: Next-Generation Sequencing of 4,871 Patients. 2017 Apr 15 1
3 27496134 Preclinical Modeling of KIF5B-RET Fusion Lung Adenocarcinoma. 2016 Oct 2
4 25982012 Systemic and CNS activity of the RET inhibitor vandetanib combined with the mTOR inhibitor everolimus in KIF5B-RET re-arranged non-small cell lung cancer with brain metastases. 2015 Jul 1